Report on the 2025 Long

News Highlights

Report on the 2025 Long-Term Care Management Symposium. This symposium presented the value of choosing third-party succession as an option for successor issues in medical M&A and business succession, rather than closing or ceasing operations. The chairperson and director highlighted the importance of early preparation over a 5-10 year span starting around age 60, and the utilization of specialized advisors focused on the medical industry as key discussion points.

Perspective from M&A Medical Editorial Department

The report on the 2025 Long-Term Care Management Symposium is significant in that it reaffirmed the viability of “third-party succession” as an alternative to closure or cessation of operations for business succession issues faced by medical institution management. In particular, the point that chairpersons and directors should begin preparations over a long-term span of 5-10 years starting around age 60 presents a reality that is not a distant concern for many medical institutions. For example, if a clinic that has long served regional healthcare in a provincial city were to close due to a lack of successors, the medical vacuum in that area would become severe. To avoid such a situation and continue contributing to the region, the expertise and know-how in medical succession, held by specialized advisors like M&A Medical who focus on the medical industry, become indispensable. The points raised in the symposium can be interpreted as advocating for the necessity of business succession from the perspective of “sustainable regional healthcare,” not just “succession.”

Key Discussion Points from This News

• Reaffirms that “third-party succession” is a viable alternative to closure or cessation of operations.
• Emphasizes the importance for chairpersons and directors to begin business succession preparations in 10-year increments starting around age 60.
• The utilization of specialized advisors focused on the medical industry is key to smooth third-party succession.
• Suggests the need to view business succession issues from the perspective of regional healthcare sustainability.

Practical Questions Arising from This News

• When considering third-party succession, what specific types of medical institutions are potentially eligible?
• Assuming preparation begins around age 60, what concrete steps should be taken for information gathering and consulting with experts?
• If a specialized advisor is engaged, what is the estimated cost and what kind of support can be expected?

If You Feel “Should I Consult Too?”

If your institution’s chairperson or director is approaching age 60 and feels vague anxiety about successor issues, or is beginning to consider future closure or cessation of operations, it may be time to explore the possibility of third-party succession. M&A Medical will conduct a detailed interview of your institution’s situation and provide individual explanations on whether third-party succession can be a realistic option, its merits and demerits, and the concrete steps for early preparation.

M&A Medical (CentralMedience Inc.) supports the business succession of medical corporations, hospitals, and clinics on a full success fee basis as an M&A support institution certified by the Small and Medium Enterprise Agency. Consultations are accepted with strict confidentiality. [Free consultation here](https://ma-med.net/contact/).